RESUMO
The walrus, Odobenus rosmarus, is an iconic pinniped and predominant molluscivore that is well adapted to Arctic and subarctic environments. Its circumpolar distribution, large body size and ivory tusks facilitated its vital role as food, raw material (for tools and art), income, and cultural influence on many Arctic Indigenous communities for millennia. Intensification of hunting (often due to the arrival of Europeans, especially between the 16 th and 19 th centuries) to obtain ivory, hide, blubber and meat, resulted in diminished, sometimes extirpated, walrus populations. Zooarchaeological, artefactual and documentary evidence of walrus material has been collated at local and regional scales and is frequently focused on a specific culture or period of time. Systematic collation of this evidence across the Northern Hemisphere will provide insight into the chronology and circumpolar distribution of walrus hunting and provide a tool to document societal change in walrus resource use. Here, we lay out a systematic review protocol to collate records of archaeological walrus artefacts, tusks and bones that have been documented primarily within published literature to archive when and where (as feasible) walrus extractions occurred between 1 CE and 2000 CE. These data will be openly available for the scientific community. The resulting dataset will be the first to provide spatiotemporal information (including the recognition of knowledge gaps) regarding past walrus populations and extirpations on a circumpolar scale. Our protocol is published to ensure reproducibility and comparability in the future, and to encourage the adoption of systematic review methodology (including pre-published protocols) in archaeology.
RESUMO
Archaeological faunal remains provide key insights into human societies in the past, alongside information on previous resource utilisation and exploitation of wildlife populations. The great whales (Mysticete and sperm whales) were hunted unsustainably throughout the 16th - 20th centuries (herein defined as the modern period) leading to large population declines and variable recovery patterns among species. Humans have utilised whales as a resource through carcass scavenging for millennia; however, increasing local and regional ethnographic and archaeological evidence suggests that, prior to the modern period, hunting of the great whales was more common than previously thought; impacts of earlier hunting pressures on the population ecology of many whale species remains relatively unknown. Hunting guided by traditional ecological knowledge may have been sustainable and likely originated in societies that also incorporated opportunistic use of stranded individuals. The collation of georeferenced zooarchaeological data of the great whales between the 1st - 20th centuries CE worldwide will provide insight into the timescale and distribution of resource utilisation of the great whales and how this varied within and between societies, and may have changed over time. By comparing regions of known resource utilisation and breeding and feeding grounds of current-day whale populations, this information will subsequently be used to infer regions where whale populations were possibly lost or extirpated prior to detailed historical records. This systematic review protocol also provides a template for archaeologists, ecologists, and historians interested in using faunal remains to infer historical ecology and resource use of wild animal populations. The transparency of our data collection approach provides opportunities for reproducibility and comparability with future datasets.
Assuntos
Cachalote , Baleias , Animais , Humanos , Reprodutibilidade dos Testes , Revisões Sistemáticas como Assunto , Coleta de Dados , Animais SelvagensRESUMO
Domestic dogs have been central to life in the North American Arctic for millennia. The ancestors of the Inuit were the first to introduce the widespread usage of dog sledge transportation technology to the Americas, but whether the Inuit adopted local Palaeo-Inuit dogs or introduced a new dog population to the region remains unknown. To test these hypotheses, we generated mitochondrial DNA and geometric morphometric data of skull and dental elements from a total of 922 North American Arctic dogs and wolves spanning over 4500 years. Our analyses revealed that dogs from Inuit sites dating from 2000 BP possess morphological and genetic signatures that distinguish them from earlier Palaeo-Inuit dogs, and identified a novel mitochondrial clade in eastern Siberia and Alaska. The genetic legacy of these Inuit dogs survives today in modern Arctic sledge dogs despite phenotypic differences between archaeological and modern Arctic dogs. Together, our data reveal that Inuit dogs derive from a secondary pre-contact migration of dogs distinct from Palaeo-Inuit dogs, and probably aided the Inuit expansion across the North American Arctic beginning around 1000 BP.
Assuntos
Distribuição Animal , Cães/anatomia & histologia , Cães/genética , Genoma Mitocondrial , Fenótipo , Alaska , Animais , Arqueologia , Regiões Árticas , Canadá , DNA Antigo/análise , DNA Mitocondrial/análise , Groenlândia , Migração HumanaRESUMO
Ketorolac tromethamine is a racemic, non-steroidal, anti-inflammatory drug (NSAID). An intra-nasal (IN) formulation, SPRIX(®), is approved for the treatment of short term (up to 5 days) acute moderate to moderately severe pain. The primary objective of this study was to determine whether (99m)Tc-diethylenetriaminepenta acetic acid (DTPA) radiolabelled ketorolac tromethamine formulation (31.5 mg) was deposited in the lungs of healthy subjects (4 men and 9 women) following nasal inhalation of different intensities (gentle or vigorous sniff) and under different postural conditions (upright or semi-supine). The secondary objectives were to determine the deposition pattern of radiolabelled ketorolac solution in the nasal cavity and the clearance of the radiolabel over a 6h period post-administration. The nasal spray pump delivery device used showed a droplet size distribution with a volume mean diameter (VMD) of 50 µm and approximately 85% of the aerosol mass contained in droplets >10 µm diameter. The fraction of the dose recorded from the lung regions averaged <0.5%, and was considered to represent scattered radiation rather than true pulmonary deposition. This fraction was not affected by posture or by inhalation manoeuvre. The majority of the radiolabelled intranasal dose was deposited in the nasal cavity. The visual spread patterns within the nasal cavity were most uniform following administration in the upright position regardless of inhalation manoeuvre. Clearance from the nasal cavity was initially very rapid, with only 16-30% of the dose remaining after 10 min and 6-14% after 6 h. Retention was greatest following gentle inhalation.
Assuntos
Anti-Inflamatórios não Esteroides/farmacocinética , Cetorolaco de Trometamina/farmacocinética , Pulmão/metabolismo , Cavidade Nasal/metabolismo , Administração Intranasal/métodos , Adulto , Anti-Inflamatórios não Esteroides/administração & dosagem , Anti-Inflamatórios não Esteroides/efeitos adversos , Estudos Cross-Over , Esôfago/metabolismo , Feminino , Mucosa Gástrica/metabolismo , Humanos , Cetorolaco de Trometamina/administração & dosagem , Cetorolaco de Trometamina/efeitos adversos , Masculino , Pessoa de Meia-Idade , PosturaAssuntos
Glycine max , Saúde Holística , Recursos Humanos de Enfermagem/psicologia , Probióticos , Salix , HumanosRESUMO
Whole lung and regional lung deposition of inhaled asthma drugs in the lungs can be quantified using either two-dimensional or three-dimensional radionuclide imaging methods. The two-dimensional method of gamma scintigraphy has been the most widely used, and is currently considered the industry standard, but the three-dimensional methods (SPECT, single photon emission computed tomography; and PET, positron emission tomography) give superior regional lung deposition data and will undoubtedly be used more frequently in future. Recent developments in radionuclide imaging are described, including an improved algorithm for assessing regional lung deposition in gamma scintigraphy, and a patent-protected radiolabelling method (TechneCoat), applicable to both gamma scintigraphy and SPECT. Radionuclide imaging data on new inhaled asthma products provide a milestone assessment, and the data form a bridge between in vitro testing and a full clinical trials program, allowing the latter to be entered with increased confidence.